![](https://d197nivf0nbma8.cloudfront.net/uploads/2024/07/Penn-LDI-LinkedIn_Policy-RachelNorma2-520x438.jpg)
Briefing: The Impact of Repealing the Centers for Medicare and Medicaid Services Minimum Staffing Rule on Patient Outcomes
Presented to U.S. Senator Elizabeth Warren
In Their Own Words
The following excerpt is from an op-ed that first appeared in the Philadelphia Inquirer on February 28th, 2024.
My patient — we’ll call her Sydney — was a young teenager who had been sick for weeks. We ultimately diagnosed her with an aggressive, rare disorder of the blood vessels that can restrict blood flow and damage vital organs.
Sydney received Remicade, a targeted, immunosuppressive medication known as a biologic during her hospitalization, and it worked. Her fevers abated, her energy returned, and her labs showed dramatic improvement. Yet, despite Sydney’s visible improvement during her hospital stay, her insurance provider denied payment for her Remicade treatments when she went home.
After an initial letter explaining the necessity of her medication, followed by a 75-minute phone call with Sydney’s insurance company three weeks later, we ultimately got her medication approved, four weeks after we prescribed it. Fortunately, Sydney was only one day late for her monthly dose.
Unfortunately, I have many other patients whose struggles with insurance over medication coverage haven’t ended so well.
As a pediatric rheumatologist, I care for children with rare forms of chronic illness for which we now have highly effective therapies. But too often, my patients can’t access these effective therapies because insurers put up many barriers to coverage.
Read the entire op-ed here.
Presented to U.S. Senator Elizabeth Warren
The Braidwood Case Opens the Door For Others To Block PrEP and other Preventive Services
Changing the Health Care Reimbursement Model Could Improve Quality and Lower Costs
Using Nudges Like Text Messages Can Help Make Public Health Gains
Evidence Points to Health Improvements Linked to Tax Credit Payments
Concerns Remain About Measuring Racism. LDI Experts Weigh in on How HCAHPS Surveys Can Be Improved